Mandate

Vinge has advised Scandic in connection with its repurchase of convertible bonds

Vinge has advised Scandic Hotels Group AB (publ) (”Scandic”) in connection with its repurchase of convertible bonds.

In total, convertible bonds with an aggregate nominal amount of SEK 590.2 million were repurchased through an modified Dutch auction procedure.

Scandic is the largest hotel company in the Nordic countries with a network of about 280 hotels with 58,000 rooms in operation and under development, in more than 130 destinations. Scandic is listed on Nasdaq Stockholm.

Vinge’s team has consisted of Jesper Schönbeck, Amanda Knutsson, William Kåge, Lovisa Jonassen (Capital markets and public M&A), Louise Brorsson Salomon and Arvid Weimers (Banking and finance)

Related

Vinge has advised Egetis Therapeutics in connection with a directed share issue

Vinge has advised Egetis Therapeutics AB (publ) (“Egetis Therapeutics”), listed on Nasdaq Stockholm, in connection with a directed share issue whereby Egetis Therapeutics raised proceeds of approximately SEK 183 million before transaction costs.
October 06, 2025

Vinge worked with funds advised by Agilitas on the buy-out of Vivicta (previously Tietoevry Tech Services), including on the issuance of senior secured bonds and on entering into a super senior RCF

Vinge, together with O’Melveny as lead counsel and Avance, worked with funds advised by Agilitas Private Equity LLP (“Agilitas”), the pan-European mid-market private equity firm, in their backing of Vivicta. The buy-out was previously announced on 24 March 2025 and closed on 2 September 2025.
October 03, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 671.5 million

Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue through which the company raises proceeds of approx. SEK 671.5 million before transaction costs.
October 03, 2025